For example, although ER+ tumors account for the majority of all human breast cancers, stably ER+ mouse mammary tumors have been difficult to obtain and the genetic changes that lead to ER expression in mouse tumors are frequently not characteristic of patients’ ER+ tumors (Mohibi et al,2011). The gene discussed is ESR1; the disease is breast carcinoma.